Innovotech (CVE:IOT) Hits New 1-Year Low – Should You Sell?

Innovotech Inc. (CVE:IOT)’s share price reached a new 52-week low during trading on Thursday. The company traded as low as C$0.07 and last traded at C$0.07, with a volume of 25544 shares. The stock had previously closed at C$0.08.

Innovotech Stock Performance

The company has a market cap of C$3.81 million, a P/E ratio of -5.00 and a beta of 2.52. The firm’s fifty day moving average price is C$0.08 and its 200-day moving average price is C$0.12. The company has a current ratio of 2.63, a quick ratio of 5.81 and a debt-to-equity ratio of 12.55.

Innovotech Company Profile

Innovotech Inc provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services.